578-57-4

Applied Filters:

Keyword:'578-57-4'

Showing 1-2 of 2 results for "578-57-4" within Papers

Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.

Daniela Gustinucci et al.

Acta cytologica, 56(5), 506-514 (2012-10-19)

We evaluated the performance of cytologic p16(INK4a) (p16) immunostaining within a cervical cancer screening program for the categories of atypical squamous cells of undetermined significance (ASC-US) and low-grade squamous intraepithelial lesion (LS after triage with high-risk human papillomavirus (HR-HPV) testing

Pneumonitis in Patients Treated With Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy.

Jarushka Naidoo et al.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 35(7), 709-717 (2016-09-21)

Purpose Pneumonitis is an uncommon but potentially fatal toxicity of anti-programmed death-1 (PD-1)/programmed death ligand 1 (PD-L1) monoclonal antibodies (mAbs). Clinical, radiologic, and pathologic features are poorly described. Methods Patients who received anti-PD-1/PD-L1 monotherapy or in combination with anti-cytotoxic T-cell

Page 1 of 1